Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof
Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692)
12/2010
12/16/2010WO2010142058A1 Peptide derivatives with endothelin receptor antagonizing activity, pharmaceutical compositions and uses thereof
12/16/2010WO2010076654A3 Cysteine-free technetium (tc) or rhenium (re) chelating peptide tags and their use
12/16/2010US20100317831 Probe compounds for protein tyrosine phosphatase (ptp) and precursors thereof
12/16/2010US20100317600 Process for Preparing Cardiodilatin Fragments; Highly Purified Cardiodilatin Fragments and Intermediate Products for the Preparation of Same
12/16/2010US20100316714 Methods of treating disease with random copolymers
12/16/2010CA2847910A1 Anti-viral compounds
12/15/2010EP2261710A1 Optical coupling device with optical waveguide coupled to optical device
12/15/2010EP2261709A1 Optical coupling device with optical waveguide coupled to optical device
12/15/2010EP2261246A2 Binding polypeptides for B-lymphocyte stimulator protein (BLyS)
12/15/2010EP2261236A2 Composition for proteasome inhibition
12/15/2010EP2261235A2 Inhibitors of caspases
12/15/2010EP2261234A2 Inhibitors of caspases
12/15/2010EP2261233A2 Inhibitors of caspases
12/15/2010EP2261232A2 Inhibitors of caspases
12/15/2010EP2260843A2 Alpha-MSH and derivatives for the induction of tolerance against antigens
12/15/2010CN1852920B Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
12/15/2010CN101914376A Peptidomimetic fluorescent ion probe and application thereof in metal ion detection
12/15/2010CN101914134A Linear epitope minimum motif peptide of human papilloma virus type 58 E7 protein
12/15/2010CN101914133A Directional synthesis method for 21(S) argatroban
12/15/2010CN101914132A Crystal structure of 21(S) argatroban
12/15/2010CN101245096B Liquid phase synthesizing method for N-benzyl oxylcarbonyl isoleucyl -beta-tert-butyl glutamyl-alanyl-amino aldehyde
12/15/2010CN101143891B Technique for separating and purifying oxidation resistance dipeptide in protamine hydrolyzate
12/14/2010US7851591 peptide that binds to a human major histocompatibility complex class I A molecule; for treating a patient that has or is at risk of having a cell that expresses telomerase catalytic subunit (hTERT)
12/14/2010US7851586 Peptides for activation and inhibition of δPKC
12/14/2010US7851449 peptide lysyl-glutamyl-asparagine acid capable of enhancing capillaries resistance; for treatment of purpura senilis; normalization of blood microcirculation
12/14/2010US7851448 adminstering a polypeptide optionally having one conservative amino acid substitutions, which can be used to treat, prevent, and modulate metabolic condition in plants
12/14/2010US7851433 Method of purifying TFPI and TFPI analogs
12/14/2010CA2285937C Modified proteins which bind extracellular matrix components
12/09/2010WO2010140625A1 Process for production of reduced glutathione
12/09/2010WO2010000801A3 Whey protein hydrolysate containing tryptophan peptide consisting of alpha lactalbumin and the use thereof
12/09/2010US20100311690 Boropeptide inhibitors of enteropeptidase and their uses in treatment of obesity, overweight and/or diseases associated with an abnormal fat metabolism
12/09/2010US20100311667 Novel compounds, use thereof in cosmetic and cosmeceutic applications, and compositions comprising same
12/09/2010US20100311640 Self-assembling peptide incorporating modifications and methods of use thereof
12/09/2010US20100310640 Hla-dr binding peptides and their uses
12/09/2010US20100310595 Method of transfection and compositions therefor
12/09/2010US20100310484 Novel peptides, use thereof in cosmetic and cosmeceutic applications, and compositions comprising same
12/09/2010US20100310455 Heterocyclic Ligands for Integrin Imaging and Therapy
12/08/2010EP2259064A2 Peptide compounds for detecting or inhibiting SARS coronavirus and application thereof
12/08/2010EP2258853A1 Lipolytic enzyme variant
12/08/2010EP2258852A1 Lipolytic enzyme variant
12/08/2010EP2258835A1 Lipolytic enzyme variant
12/08/2010EP1438329B1 Biologically active peptides and their use for repairing injured nerves
12/08/2010CN101910195A Macrocyclic inhibitors of hepatitis c virus NS3 serine protease
12/08/2010CN101906138A Pseudo cyclic polypeptide and synthesis method and application thereof
12/08/2010CN101906137A Conjugate of Arg-Gly-Asp chain and two fatty alcohol chains, synthesis and medical application thereof
12/08/2010CN101906136A Amino acid-(3,4-dyhydroxy-Phe)-Ser-Leu false peptide, and synthesizing method and application thereof
12/08/2010CN101906135A Novel spirulina source antihypertensive peptide and preparation method thereof
12/08/2010CN101906134A Peptidic compounds
12/08/2010CN101906133A Preparation method and application of corn angiotensin converting enzyme inhibitory peptide
12/08/2010CN101906097A 1,3-dioxane compounds as well as synthesizing method and medical application thereof
12/08/2010CN101143892B Method for resolving enantiomer by enzyme catalysis
12/08/2010CN101045745B Scale preparation method of bursin and application of used as avian influema vaccine adjuvant
12/07/2010US7847058 Method of modulating cell survival, differentiation and/or synaptic plasticity
12/07/2010US7846900 derived from atrial natriuretic peptide prohormone; adenocarcinomas; side effect reduction
12/07/2010CA2327938C Aspartyl dipeptide ester derivatives and sweeteners
12/02/2010WO2010138889A1 Peptides for the treatment of hcv infections
12/02/2010WO2010136617A1 Polymeric conjugate for treating bacterial infections
12/02/2010WO2010117725A3 Production of peptides containing poly-gly sequences using fmoc chemistry
12/02/2010CA2763638A1 Iap inhibitors
12/02/2010CA2763614A1 Iap inhibitors
12/01/2010EP2254908A1 Cosmetic or pharmaceutical compositions comprising metalloproteinase inhibitors
12/01/2010EP2134739B1 Sulfur compounds as inhiibitors of hepatitis c virus ns3 serine protease
12/01/2010EP1806141B1 Par-2 antagonists
12/01/2010EP1765850B1 Substituted propane phosphinic acid derivatives
12/01/2010EP1648922B1 Spatially-defined macrocyclic compounds useful for drug discovery
12/01/2010CN101899090A Saturated fatty chain alcohol His-Gly-AA tripeptide ester, synthetic method and application thereof
12/01/2010CN101899089A Saturated fatty chain amine His-Gly-AA tripeptide amide, synthetic method and application thereof
12/01/2010CN101899088A Saturated fat chain acid His-Gly-AA tripeptide amide, and synthesis method and use thereof
12/01/2010CN101899087A Saturated fatty chain amine Glu-Asp-Gly tripeptide amides as well as synthesis method and application thereof
12/01/2010CN101899086A Saturated fatty chain acid Glu-Asp-Gly tripeptide amide, synthetic method and application thereof
12/01/2010CN101899085A Saturated fatty chain alcohol Glu-Asp-Gly tripeptide ester, synthetic method and application thereof
12/01/2010CN101899084A (3S)-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid kyrine conjugate, preparation method and application thereof
12/01/2010CN101899062A Synthesis technology of alpha-chiral boric acid and boric acid ester
12/01/2010CN101190941B Polypeptide with thrombus dissolving activity and its preparation method and application
11/2010
11/30/2010US7842782 Heparanase-derived peptides for vaccination of tumor patients
11/30/2010US7842671 Blocking cancer cells; antiproliferative agents; inducting apoptosis; anticancer, antitumor agents; peptidomimetics
11/30/2010US7842480 Protein fusion comprising transport domain for use in treatment and prevention of viral inection and cell proliferative disorders
11/30/2010CA2193969C Peptide, a method of obtaining it and a pharmaceutical compound based on it
11/30/2010CA2144474C Substituted n-ethylglycine derivatives for preparing pna and pna/dna hybrids
11/25/2010WO2010135180A1 Catalysis of fluorine addition to double bonds
11/25/2010WO2010134305A1 Peptidic antigen that induces antibody recognizing three-dimensional structure of hiv and method for synthesizing same
11/25/2010WO2010133000A1 Selective caspase inhibitors and uses thereof
11/25/2010WO2010112713A3 Proteasome-activating lightening peptides and compositions containing same
11/25/2010WO2010112712A3 Novel proteasome-activating anti-aging peptides and compositions containing same
11/25/2010WO2010112711A3 Novel proteasome-activating lightening peptides and compositions containing same
11/25/2010WO2010112710A3 Proteasome-activating anti-aging peptides and compositions containing same
11/25/2010WO2009142842A9 Novel macrocyclic inhibitors of hepatitis c virus replication
11/25/2010US20100298235 Epithelial cell growth promoter
11/25/2010US20100298210 HCV NS3 Protease Inhibitors
11/25/2010US20100298209 Compounds for preventing or treating a viral infection
11/25/2010US20100297017 Method for Synthesizing and Using Pegylated Peptide-Photoactive Chromophore Conjugates and Micellular Formulations Thereof
11/25/2010CA2763122A1 Bimacrocyclic hcv ns3 protease inhibitors
11/24/2010EP2252576A2 Selective poly-n-substituted glycine antibiotics
11/24/2010EP2252310A1 Heterocyclic peptide ketoamides
11/24/2010CN101891739A Pyridino-uracil peptide nucleic acid monomer and intermediate thereof as well as preparation method and application of same
11/23/2010US7838560 Urokinase inhibitors, production and use thereof
11/23/2010US7838491 controlling hydroxyapatite crystal growth; stabilized cylindrical micelles; bone disorders
11/23/2010US7838002 decrease inhibit or prevent viral propagation or screening of compounds impaction on the expression of shorter form core+1 protein; antiviral agents
11/18/2010WO2010132603A1 Method and apparatus for the analysis and identification of molecules
11/18/2010WO2010074542A3 NANOSTRUCTURES HAVING STABILIZED MULTIPLE α-HELICAL STRUCTURES, SELF-ASSEMBLING MACROCYCLIC COMPOUNDS FOR FORMING THE NANOSTRUCTURES, AND METHODS OF PREPARING THE COMPOUND
1 ... 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 ... 307